Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -37.23% · OPTIONAL
· Medicinal Chemicals & Botanical Products
RESEARCH SNAPSHOTSynergy CHC Corp.'s latest supported as-filed period reports revenue of $5.5M, 32.8% below the comparable as-filed period; gross margin moved 315 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -37.23% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -32.77% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 61.57% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 72.29% · CORE
Level · gp.fundamentals.operating_margin
Raw value -10.32% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2.12% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Gross margin moved 315 bp lower; Operating margin moved 3416 bp lower.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Shares outstanding increased 65.3%; SBC / revenue moved 212 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 44.1%; Inventory / revenue moved 3285 bp higher.
2 evidence-backed componentsOperating margin changed -3416 basis points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
SNYR · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001213900-26-097802SEC ↗8-KAug 26, 2026Period Aug 25, 20260001213900-26-093728SEC ↗8-KAug 21, 2026Period Aug 20, 20260001213900-26-092335SEC ↗8-KAug 11, 2026Period Aug 11, 20260001213900-26-087826SEC ↗8-KJul 29, 2026Period Jul 15, 20260001213900-26-082791SEC ↗4Jul 1, 2026Period Jun 29, 20260001903189-26-000002SEC ↗4Jul 1, 2026Period Jun 29, 20260001903192-26-000002SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Gross margin changed -315 basis points from the comparable as-filed period.
Operating cash flow changed -148.5% from the comparable as-filed period.
Revenue changed -32.8% from the comparable as-filed period.
Gross profit changed -35.6% from the comparable as-filed period.
Shares outstanding changed +65.3% from the comparable as-filed period.
Cash & equivalents changed +64.2% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-03-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001626921-26-000002